AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: Avecho Investor Update, page-3

  1. 2,638 Posts.
    lightbulb Created with Sketch. 773
    Interesting read. Would have thought we have made more progress on the daptomycin and Propofol fronts. Seems like a lot of the business development discussion terminology has been dropped. The Animal health has all but died. I mean honestly why the heck are they referring to multiple companies still analysing this.
    The cannabis sector seems the focus for short term cash.
    Why are they able to suggest a timeline for cannabis side of the business but not the other parts?
    I hope we get more from the webiner.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $936 350.4K

Buyers (Bids)

No. Vol. Price($)
48 94291923 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20075996 11
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.